Reply
Main Authors: | David Felson, Michael LaValley, Diane Lacaille, Daniel Aletaha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11401 |
Similar Items
-
Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C‐Reactive Protein, and Patient Global Assessment
by: David T. Felson, et al.
Published: (2022-02-01) -
Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight–joint Disease Activity Score, C-reactive protein level and patient global assessment
by: David Felson, et al.
Published: (2021-12-01) -
Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis.
by: Andreea M Bujor, et al.
Published: (2019-01-01) -
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
by: Revathi Ananthakrishnan, et al.
Published: (2019-12-01) -
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
by: Revathi Ananthakrishnan, et al.
Published: (2018-06-01)